1 Product identity
Ingredient risk
Contains restricted ingredients

Xtreme Mass

BrandFusion SupplementsNon-Nutrient/Non-Botanical Capsule 6 ingredients 1 banned 1 caution DSLD #33356
Net contents: 60 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2014-05-23
2 Ingredients (6)
IngredientGroupSafety
13-Ethyl-3-Methoxy-Gona-2, 5(10)-Diene-17-One13-Ethyl-3-Methoxy-Gona-2,5(10)-Diene-17-One
Magnesium StearateMagnesium stearateUse with Caution
MaltodextrinMaltodextrin
GelatinGelatin
Titanium DioxideTitanium DioxideBanned in ≥1 country
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Titanium Dioxide  🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
DIM — Limited Evidence
⚠ Anti-estrogenic effects
⚠ Hormonal disruption possible
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Titanium Dioxide — Banned in ≥1 country
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
4 Label claims
• No Claim
5 Data source
DSLD ID33356
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2014-05-23
6 More from Fusion Supplements
View Fusion Supplements Safety Scorecard → 3 products
Halodrol 25 mgHalodrol 25 mg
7 Cite this page
Vancouver
Pkhakadze G. Xtreme Mass — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 01]. Available from: https://supplement.ge/products/xtreme-mass-33356/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG